Telomere Therapeutics Establishes Scientific Advisory Board to Support the Advancement of its Gene Therapy Pipeline
Telomere Therapeutics Establishes Scientific Advisory Board to Support the Advancement of its Gene Therapy Pipeline Telomere Therapeutics has established its Scientific Advisory Board (SAB), bringing together internationally recognized leaders in telomere biology, gene therapy, pulmonary medicine, translational research, and drug development to support the advancement of the Company’s therapeutic pipeline. The Scientific Advisory Board will […]
Telomere Therapeutics Receives EMA Orphan Drug Designation for AAV-TERT-01
Telomere Therapeutics Receives EMA Orphan Drug Designation for AAV-TERT-01 Telomere Therapeutics has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for AAV-TERT-01, its investigational gene therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF). The designation recognizes the potential of AAV-TERT-01 to address a rare disease with significant unmet medical need and provides regulatory incentives to […]
Telomere Therapeutics Receives Comunidad de Madrid Grant Supporting EIC Accelerator Seal of Excellence Projects
Telomere Therapeutics has been awarded the Seal of Excellence Grant by the Comunidad de Madrid Telomere Therapeutics has been awarded the Seal of Excellence Grant by the Comunidad de Madrid, through the Dirección General de Investigación e Innovación Tecnológica, following the Company’s successful receipt of the prestigious European Innovation Council (EIC) Accelerator Seal of Excellence under the Horizon Europe programme. The funding will support the continued development of AAV-TERT-01, the Company’s investigational gene therapy for Idiopathic Pulmonary Fibrosis (IPF). Specifically, the grant will finance key Chemistry, […]
Muñoz-Lorente MA, Cano-Martin AC, Blasco MA. Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Nat Commun. 2019 Oct 17;10(1):4723. doi: 10.1038/s41467-019-12664-x
Povedano JM, Martinez P, Serrano R, Tejera Á, Gómez-López G, Bobadilla M, Flores JM, Bosch F, Blasco MA. Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres. Elife. 2018 Jan 30;7:e31299. doi: 10.7554/eLife.31299.
Muñoz-Lorente MA, Martínez P, Tejera Á, Whittemore K, Moisés-Silva AC, Bosch F, Blasco MA. AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer. PLoS Genet. 2018 Aug 16;14(8):e1007562. doi: 10.1371/journal.pgen.1007562.
Povedano JM, Martinez P, Flores JM, Mulero F, Blasco MA. Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction. Cell Rep. 2015 Jul 14;12(2):286-99. doi: 10.1016/j.celrep.2015.06.028.
Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med. 2012 Aug;4(8):691-704. doi: 10.1002/emmm.201200245